Published in J Virol on June 01, 1983
Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA. J Virol (1986) 2.33
Analysis of retroviral pol gene products with antisera raised against fusion proteins produced in Escherichia coli. J Virol (1986) 2.18
An internal ribosomal entry mechanism promotes translation of murine leukemia virus gag polyprotein precursors. J Virol (1995) 1.80
A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses. J Virol (1994) 1.64
Monoclonal antibody to the amino-terminal L sequence of murine leukemia virus glycosylated gag polyproteins demonstrates their unusual orientation in the cell membrane. J Virol (1986) 1.22
Characterization of monoclonal antibodies against the human immunodeficiency virus matrix protein, p17gag: identification of epitopes exposed at the surfaces of infected cells. J Virol (1991) 1.21
A membrane-associated, carbohydrate-modified form of the v-abl protein that cannot be phosphorylated in vivo or in vitro. J Virol (1984) 1.05
Characterization of gP85gag as an antigen recognized by Moloney leukemia virus-specific cytolytic T cell clones that function in vivo. J Exp Med (1985) 1.00
A new retroelement constituted by a natural alternatively spliced RNA of murine replication-competent retroviruses. EMBO J (2003) 0.91
The Nef-like effect of murine leukemia virus glycosylated gag on HIV-1 infectivity is mediated by its cytoplasmic domain and depends on the AP-2 adaptor complex. J Virol (2014) 0.90
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem (1974) 113.22
An efficient mRNA-dependent translation system from reticulocyte lysates. Eur J Biochem (1976) 46.42
Nucleotide sequence of Moloney murine leukaemia virus. Nature (1981) 24.82
Identification of an Abelson murine leukemia virus-encoded protein present in transformed fibroblast and lymphoid cells. Proc Natl Acad Sci U S A (1978) 6.38
Measurement of the sequence complexity of cloned Moloney murine leukemia virus 60 to 70S RNA: evidence for a haploid genome. J Virol (1974) 4.84
gag Gene of mammalian type-C RNA tumour viruses. Nature (1976) 4.11
Relationship of retrovirus polyprotein cleavages to virion maturation studied with temperature-sensitive murine leukemia virus mutants. J Virol (1978) 4.06
The Fv-1 gene of the mouse and its control of murine leukemia virus replication. Curr Top Microbiol Immunol (1979) 3.45
Virus-specific precursor polypeptides in cells infected with Rauscher leukemia virus: synthesis, identification, and processing. Virology (1976) 3.26
Cells nonproductively transformed by Abelson murine leukemia virus express a high molecular weight polyprotein containing structural and nonstructural components. Proc Natl Acad Sci U S A (1978) 2.90
Cleavage at Asn-Gly bonds with hydroxylamine. Methods Enzymol (1977) 2.80
gag-Related polyproteins of Moloney murine leukemia virus: evidence for independent synthesis of glycosylated and unglycosylated forms. J Virol (1979) 2.68
Virus-specific precursor polypeptides in cells infected with Rauscher leukemia virus. Virology (1975) 2.55
Synthesis and glycosylation of polyprotein precursors to the internal core proteins of Friend murine leukemia virus. J Virol (1977) 2.26
Post-translational modification of Rauscher leukemia virus precursor polyproteins encoded by the gag gene. J Virol (1979) 2.16
Cleavage at aspartyl-prolyl bonds. Methods Enzymol (1977) 2.10
RNA sequencing provides evidence for allelism of determinants of the N-, B- or NB-tropism of murine leukemia viruses. Cell (1979) 1.88
Sequence relationship of glycosylated and unglycosylated gag polyproteins of Moloney murine leukemia virus. J Virol (1980) 1.83
Murine leukemia virus gag polyproteins: the peptide chain unique to Pr80 is located at the amino terminus. Virology (1978) 1.73
Characterization of molecular species carrying gross cell surface antigen. J Virol (1977) 1.69
Intracistronic mapping of the murine type C viral gag gene by use of conditional lethal replication mutants. Virology (1977) 1.68
Tryptic peptide analysis of gag and gag-pol gene products of Rauscher murine leukemia virus. J Virol (1979) 1.61
Identification of the Gross cell surface antigen associated with murine leukemia virus-infected cells. J Virol (1977) 1.54
Characterization of 40,000- and 25,000-dalton intermediate precursors to Rauscher murine leukemia virus gag gene products. J Virol (1979) 1.40
Biosynthesis and metabolism of viral proteins expressed on the surface of murine leukemia virus-infected cells. Virology (1978) 1.39
Structure of glycosylated and unglycosylated gag polyproteins of Rauscher murine leukemia virus: carbohydrate attachment sites. J Virol (1981) 1.39
Abrogation of Fv-1b restriction with murine leukemia viruses inactivated by heat or by gamma irradiation. J Virol (1978) 1.11
Two-dimensional analysis of murine leukemia virus gag-gene polyproteins. Virology (1979) 1.08
Fate of unintegrated viral DNA in Fv-1 permissive and resistant mouse cells infected with murine leukemia virus. J Virol (1981) 1.00
An improved method for the preparation of undegraded polysomes and active messenger RNA from immature chicken erythrocytes. Anal Biochem (1979) 0.96
Effect of RNA tumor virus-specific protein p30 on reverse transcriptase. Intraspecies and interspecies interaction between reverse transcriptase and p30. J Biol Chem (1978) 0.85
Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell (1995) 4.32
Virus-specific precursor polypeptides in cells infected with Rauscher leukemia virus: synthesis, identification, and processing. Virology (1976) 3.26
Evolutionary conserved close linkage of the c-fes/fps proto-oncogene and genetic sequences encoding a receptor-like protein. EMBO J (1986) 2.73
Virus-specific precursor polypeptides in cells infected with Rauscher leukemia virus. Virology (1975) 2.55
WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity (2001) 2.49
Different membrane anchoring positions of tryptophan and lysine in synthetic transmembrane alpha-helical peptides. J Biol Chem (1999) 2.44
Synthesis of Rauscher murine leukemia virus-specific polypeptides in vitro. Proc Natl Acad Sci U S A (1976) 2.36
The cDNA sequence for the protein-tyrosine kinase substrate p36 (calpactin I heavy chain) reveals a multidomain protein with internal repeats. Cell (1986) 2.36
Characterization of human c-fes/fps reveals a new transcription unit (fur) in the immediately upstream region of the proto-oncogene. Mol Biol Rep (1986) 2.16
Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin. Am J Pathol (2000) 1.93
nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts. Int J Cancer (1995) 1.84
The structure of the human c-fes/fps proto-oncogene. EMBO J (1985) 1.70
Sensitivity of single membrane-spanning alpha-helical peptides to hydrophobic mismatch with a lipid bilayer: effects on backbone structure, orientation, and extent of membrane incorporation. Biochemistry (2001) 1.64
fur gene expression as a discriminating marker for small cell and nonsmall cell lung carcinomas. J Clin Invest (1987) 1.63
A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitor. J Biol Chem (1993) 1.58
Inhibition of protein kinase C by tamoxifen. Cancer Res (1985) 1.56
Identification of Rauscher murine leukemia virus-specific mRNAs for the synthesis of gag- and env-gene products. Proc Natl Acad Sci U S A (1977) 1.43
Specificity and function of the individual amino acids of an important determinant of human immunodeficiency virus type 1 that induces neutralizing activity. J Gen Virol (1989) 1.41
MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule). Am J Pathol (1998) 1.35
Expression of calcyclin in human melanoma cell lines correlates with metastatic behavior in nude mice. Cancer Res (1992) 1.28
Primary structure of bovine calpactin I heavy chain (p36), a major cellular substrate for retroviral protein-tyrosine kinases: homology with the human phospholipase A2 inhibitor lipocortin. Biochemistry (1986) 1.28
Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction. J Biol Chem (2001) 1.23
The genome of the mammalian sarcoma viruses. Biochim Biophys Acta (1978) 1.22
Impaired processing of precursor polypeptides of temperature-sensitive mutants of Rauscher murine leukemia virus. J Virol (1978) 1.20
Molecularly cloned c-mos(rat) is biologically active. EMBO J (1982) 1.17
Structure and nucleotide sequence of the 5' region of the human and feline c-sis proto-oncogenes. Nucleic Acids Res (1986) 1.16
Nucleotide sequence of the DNA region immediately upstream of the human c-sis proto-oncogene. Nucleic Acids Res (1987) 1.12
Impaired interleukin-3 response in Pim-1-deficient bone marrow-derived mast cells. Blood (1993) 1.11
Comparative analysis of the human and feline c-sis proto-oncogenes. Identification of 5' human c-sis coding sequences that are not homologous to the transforming gene of simian sarcoma virus. Biochim Biophys Acta (1985) 1.11
Regulation of maltose fermentation in Saccharomyces carlsbergensis. II. Properties of a constitutive MAL6-mutant. Mol Gen Genet (1973) 1.06
Computer-assisted molecular modeling of tumor promoters: rationale for the activity of phorbol esters, teleocidin B, and aplysiatoxin. Proc Natl Acad Sci U S A (1986) 1.05
Triphenylethylenes: a new class of protein kinase C inhibitors. J Natl Cancer Inst (1986) 1.05
Structure of the feline c-fes/fps proto-oncogene: genesis of a retroviral oncogene. J Virol (1987) 1.04
Expression of nma, a novel gene, inversely correlates with the metastatic potential of human melanoma cell lines and xenografts. Int J Cancer (1996) 1.04
Wedgelike glycodendrimers as inhibitors of binding of mammalian galectins to glycoproteins, lactose maxiclusters, and cell surface glycoconjugates. Chembiochem (2001) 1.02
Identification of melanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell lines with different metastatic capacity by messenger RNA differential display. Cancer Res (1995) 1.02
Thymosin beta-10 expression in melanoma cell lines and melanocytic lesions: a new progression marker for human cutaneous melanoma. Int J Cancer (1993) 1.01
Inhibition of neutrophil NADPH oxidase assembly by a myristoylated pseudosubstrate of protein kinase C. J Biol Chem (1993) 0.99
Expression of calcyclin in human melanocytic lesions. Cancer Res (1993) 0.98
cDNA sequence and tissue distribution of the mRNA for bovine and murine p11, the S100-related light chain of the protein-tyrosine kinase substrate p36 (calpactin I). J Biol Chem (1987) 0.96
Isolation of active ribosomal subunits from yeast. Eur J Biochem (1972) 0.96
Hydroxylamine cleavage of proteins in polyacrylamide gels. Anal Biochem (1983) 0.95
Effect of impaired glycosylation on the synthesis of envelope proteins of Rauscher murine leukemia virus. Virology (1977) 0.94
Assessment of the functional affinity constant of monoclonal antibodies using an improved enzyme-linked immunosorbent assay. J Immunol Methods (1995) 0.89
Blotting of RNA onto ion exchange paper allowing subsequent characterization by in situ translation in addition to blot hybridization. Nucleic Acids Res (1982) 0.89
Genetic organization of the c-sis transcription unit. Nucleic Acids Res (1987) 0.87
Structure-activity relationships of sparsomycin and its analogues. Inhibition of peptide bond formation in cell-free systems and of L1210 and bacterial cell growth. J Med Chem (1987) 0.87
Structural studies on Rauscher murine leukemia virus: isolation and characterization of viral envelopes. J Virol (1978) 0.86
Structure and chromosome assignment of the murine p36 (calpactin I heavy chain) gene. Biochemistry (1990) 0.86
Molecular cloning of the feline c-fes proto-oncogene and construction of a chimeric transforming gene. Gene (1985) 0.86
Characterization of the feline c-abl proto-oncogene. Biochim Biophys Acta (1985) 0.86
Effect of anisomycin on the cellular level of native ribosomal subunits. Biochemistry (1977) 0.86
Comparing mass spectrometric characteristics of peptides and peptoids. Rapid Commun Mass Spectrom (1996) 0.85
Inhibition of protein kinase C and calmodulin by the geometric isomers cis- and trans-tamoxifen. Biopolymers (1990) 0.85
The biochemical characterization of two mutant arginyl transfer ribonucleic acid synthetases from Escherichia coli K-12. J Biol Chem (1969) 0.85
Effect of ploidy on transcription levels in cultured rat aortic smooth muscle cells. FEBS Lett (1992) 0.85
Expression of tissue-type transglutaminase correlates positively with metastatic properties of human melanoma cell lines. Int J Cancer (1995) 0.85
A sensitive micro assay for inorganic pyrophosphatase. Anal Biochem (1970) 0.84
Regulation of cell specific expression of calcyclin (S100A6) in nerve cells and other tissues. Acta Neurobiol Exp (Wars) (2000) 0.83
Inhibition of IL-2 receptor induction and IL-2 production in the human leukemic cell line Jurkat by a novel peptide inhibitor of protein kinase C. Cell Immunol (1990) 0.82
Human c-fms proto-oncogene: comparative analysis with an abnormal allele. Mol Cell Biol (1985) 0.82
Cellular uptake and localization of fluorescent derivatives of phorbol ester tumor promoters. Biochem Biophys Res Commun (1985) 0.82
Synthesis of a substrate of protein kinase C and its corresponding phosphopeptide. Int J Pept Protein Res (1989) 0.82
Simultaneous suppression of progression marker genes in the highly malignant human melanoma cell line BLM after transfection with the adenovirus-5 E1A gene. Biochem Biophys Res Commun (1996) 0.82
Analysis of Pim-1 function in mutant mice. Leukemia (1993) 0.82
Synthesis of cyclic peptides by ring-closing metathesis. J Org Chem (2000) 0.81
DNase-I-hypersensitive sites located far upstream of the human c-sis/PDGF-B gene comap with transcriptional enhancers and a silencer and are preceded by (part of) a new transcription unit. Eur J Biochem (1993) 0.81
Adsorption studies of tritium-labeled peptides on polystyrene surfaces. J Immunol Methods (1998) 0.81
nmd, a novel gene differentially expressed in human melanoma cell lines, encodes a new atypical member of the enzyme family of lipases. FEBS Lett (1997) 0.80
Signals controlling the expression of PDGF. Mol Biol Rep (1997) 0.80
Complete structure of the murine p36 (annexin II) gene. Identification of mRNAs for both the murine and the human gene with alternatively spliced 5' noncoding exons. Biochim Biophys Acta (1996) 0.80
Combinatorial chemistry of hydantoins. Bioorg Med Chem Lett (1998) 0.80
Molecular aspects of pathological processes in the artery wall. Mol Biol Rep (1992) 0.80
Peptoid - peptide hybrids that bind Syk SH2 domains involved in signal transduction. Chembiochem (2001) 0.80
TNF-mediated cytotoxicity of L929 cells: role of staurosporine in enhancement of cytotoxicity and translocation of protein kinase C isozymes. Cytokine (1997) 0.80
A hereditary abnormal c-fms proto-oncogene in a patient with acute lymphocytic leukaemia and congenital hypothyroidism. Br J Haematol (1985) 0.79
The influence of binding capacity and affinity on the improved performance of N-terminally extended hCG peptides, determined by ELISA-based procedures. J Immunol Methods (1998) 0.79
Localization and functional analysis of DNase-I-hypersensitive sites in the human c-sis/PDGF-B gene transcription unit and its flanking regions. Eur J Biochem (1993) 0.79
3Y1 rat cells are defective in processing of the envelope precursor protein of AKR virus. Virology (1983) 0.79
Identification of regulatory sequences in the promoter of the PDGF B-chain gene in malignant mesothelioma cell lines. Biochim Biophys Acta (1996) 0.79
memA/DRS, a putative mediator of multiprotein complexes, is overexpressed in the metastasizing human melanoma cell lines BLM and MV3. Biochim Biophys Acta (1999) 0.79
A novel N-myristylated synthetic octapeptide inhibits protein kinase C activity and partially reverses murine fibrosarcoma cell resistance to adriamycin. Invest New Drugs (1991) 0.79
The tsA58 simian virus 40 large tumor antigen disrupts megakaryocyte differentiation in transgenic mice. Proc Natl Acad Sci U S A (1994) 0.79
Basic fibroblast growth factor has a differential effect on MyoD conversion of cultured aortic smooth muscle cells from newborn and adult rats. Am J Pathol (1993) 0.79
Molecular markers of melanocytic tumor progression. Lab Invest (1994) 0.78
Direct coating of poly(lys) or acetyl-thio-acetyl peptides to polystyrene: the effects in an enzyme-linked immunosorbent assay. Anal Biochem (1997) 0.78
Expression of the human fes cellular oncogene in renal cell tumors. Urol Res (1986) 0.78
A versatile method for the conjugation of proteins and peptides to poly[2-(dimethylamino)ethyl methacrylate]. Bioconjug Chem (1999) 0.78
Molecular diversity of peptidomimetics: approaches to the solid-phase synthesis of peptidosulfonamides. Bioorg Med Chem (1996) 0.78
Solid-phase synthesis of oligourea peptidomimetics employing the Fmoc protection strategy. J Org Chem (2001) 0.78
Expression of basic fibroblast growth factor and fibroblast growth factor receptor genes in cultured rat aortic smooth muscle cells. Biochim Biophys Acta (1995) 0.78
Molecular cloning and characterization of feline cellular genetic sequences homologous to the oncogene of the McDonough strain of feline sarcoma virus. Virology (1985) 0.77
Regulation of CD3 expression in a protein kinase C isozyme-deficient T-cell line. Immunology (1993) 0.77
Functional analysis of the human calcyclin gene promoter in a panel of human melanoma cell lines. Biochem Biophys Res Commun (1995) 0.77